Working… Menu

Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00113256
Recruitment Status : Terminated
First Posted : June 7, 2005
Last Update Posted : January 23, 2013
Information provided by (Responsible Party):
Astex Pharmaceuticals, Inc. ( Astex Pharmaceuticals )

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 2006
Study Completion Date : No date given